Phase I/II Study of Intermitted Erlotinib in Combination with Docetaxel in Patients with Recurrent NSCLC with Wild-Type EGFR: WJOG 4708L

被引：0

作者：

Kimura, T. ^{[1
]}

Kawaguchi, T. ^{[2
]}

Kudoh, S. ^{[2
]}

Chiba, Y. ^{[3
]}

Yoshioka, H. ^{[4
]}

Watanabe, K. ^{[5
]}

Kijima, T. ^{[6
]}

Kogure, Y. ^{[7
]}

Oguri, T. ^{[8
]}

Yoshimura, N. ^{[9
]}

Niwa, T. ^{[10
]}

Kasai, T. ^{[11
]}

Hayashi, H. ^{[12
]}

Ono, A. ^{[13
]}

Tanaka, H. ^{[14
]}

Yano, S. ^{[15
]}

Nakamura, S. ^{[16
]}

Yamamoto, N. ^{[17
]}

Nakanishi, Y. ^{[18
]}

Nakagawa, K. ^{[12
]}

机构：

[1] Osaka City Univ, Premier Prevent Med, Osaka, Japan

[2] Osaka City Univ, Resp Med, Osaka, Japan

[3] Kinki Univ, Fac Med, Biostat, Osaka, Japan

[4] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan

[5] Yokohama Med Ctr, Gen Thorac Surg, Yokohama, Kanagawa, Japan

[6] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka, Japan

[7] Nagoya Med Ctr, Nagoya, Aichi, Japan

[8] Nagoya City Univ, Resp Med Allergy & Clin Immunol, Nagoya, Aichi, Japan

[9] Osaka City Univ, Clin Oncol, Osaka, Japan

[10] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan

[11] Tochigi Canc Ctr, Utsunomiya, Tochigi, Japan

[12] Kinki Univ, Fac Med, Med Oncol, Osaka, Japan

[13] Shizuoka Canc Ctr, Thorac Oncol, Shizuoka, Japan

[14] Niigata Canc Ctr Hosp, Internal Med, Niigata, Japan

[15] Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa, Japan

[16] West Japan Oncol Grp, Data Ctr, Osaka, Japan

[17] Wakayama Med Coll, Dept Internal Med 3, Wakayama, Japan

[18] Kyushu Univ, Res Inst Dis Chest, Fukuoka, Fukuoka, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期

关键词：

wild-type EGFR; Erlotinib; docetaxel;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.03-008

引用

页码：S2129 / S2129

页数：1